Effects of Bioactive Dietary Components on Changes in Lipid and Liver Parameters in Women After Bariatric Surgery and Procedures

Overview

Journal Nutrients

Date 2024 May 11

PMID 38732625

Authors

Edyta Barbara Balejko

Anna Bogacka

Jaroslaw Lichota

Jan Pawlus

Affiliations

Soon will be listed here.

Abstract

Excess adipose tissue, as well as its distribution, correlates strongly with disorders of lipid and liver parameters and chronic inflammation. The pathophysiology of metabolic diseases caused by obesity is associated with the dysfunction of visceral adipose tissue. Effective and alternative interventions such as the Bioenteric Intragastric Balloon and bariatric surgeries such as the Roux-en-Y gastric bypass. The aim of this study was to assess the effect of modifying the recommended standard weight loss diet after bariatric surgery and procedures on reducing chronic inflammation in overweight patients. In the study, bioactive anti-inflammatory dietary components were used supportively. Changes in the concentrations of lipid parameters, liver parameters, antioxidant enzymes, cytokines, and chemokines were demonstrated. The enrichment of the diet, after bariatric surgery, with the addition of n-3 EFAs(Essential Fatty Acids), bioflavonoids, vitamins, and synbiotics resulted in higher weight losses in the patients in the study with a simultaneous reduction in parameters indicating liver dysfunction.

Citing Articles

Diet Biofunctionality in Modulating Cardiovascular Parameters in Obese Patients After Bioenteric Intragastric Balloon Bariatric Surgery.

Balejko E, Lichota J Nutrients. 2024; 16(23).

PMID: 39683432 PMC: 11643098. DOI: 10.3390/nu16234038.

References

Strowig T, Henao-Mejia J, Elinav E, Flavell R . Inflammasomes in health and disease. Nature. 2012; 481(7381):278-86. DOI: 10.1038/nature10759. View

Nowak J . [Anti-inflammatory pro-resolving derivatives of omega-3 and omega-6 polyunsaturated fatty acids]. Postepy Hig Med Dosw (Online). 2010; 64:115-32. View

Lu M, Cao Y, Xiao J, Song M, Ho C . Molecular mechanisms of the anti-obesity effect of bioactive ingredients in common spices: a review. Food Funct. 2018; 9(9):4569-4581. DOI: 10.1039/c8fo01349g. View

Misra H, Fridovich I . The role of superoxide anion in the autoxidation of epinephrine and a simple assay for superoxide dismutase. J Biol Chem. 1972; 247(10):3170-5. View

Kadowaki T, Yamauchi T . Adiponectin and adiponectin receptors. Endocr Rev. 2005; 26(3):439-51. DOI: 10.1210/er.2005-0005. View

Cusi K . Role of insulin resistance and lipotoxicity in non-alcoholic steatohepatitis. Clin Liver Dis. 2009; 13(4):545-63. DOI: 10.1016/j.cld.2009.07.009. View

Moro K, Nagahashi M, Ramanathan R, Takabe K, Wakai T . Resolvins and omega three polyunsaturated fatty acids: Clinical implications in inflammatory diseases and cancer. World J Clin Cases. 2016; 4(7):155-64. PMC: 4945585. DOI: 10.12998/wjcc.v4.i7.155. View

Major P, Pedziwiatr M, Rubinkiewicz M, Stanek M, Gluszewska A, Pisarska M . Impact of bariatric surgery on non-alcoholic fatty liver disease. Pol Przegl Chir. 2017; 89(2):1-4. DOI: 10.5604/01.3001.0009.6003. View

Krishnamoorthy N, Burkett P, Dalli J, Abdulnour R, Colas R, Ramon S . Cutting edge: maresin-1 engages regulatory T cells to limit type 2 innate lymphoid cell activation and promote resolution of lung inflammation. J Immunol. 2014; 194(3):863-7. PMC: 4297713. DOI: 10.4049/jimmunol.1402534. View

10.

Tilg H, Moschen A, Kaser A . Obesity and the microbiota. Gastroenterology. 2009; 136(5):1476-83. DOI: 10.1053/j.gastro.2009.03.030. View

11.

Carrasco-Pozo C, Cires M, Gotteland M . Quercetin and Epigallocatechin Gallate in the Prevention and Treatment of Obesity: From Molecular to Clinical Studies. J Med Food. 2019; 22(8):753-770. DOI: 10.1089/jmf.2018.0193. View

12.

Cunha F, Oliveira J, Preto J, Saavedra A, Costa M, Magalhaes D . The Effect of Bariatric Surgery Type on Lipid Profile: An Age, Sex, Body Mass Index and Excess Weight Loss Matched Study. Obes Surg. 2015; 26(5):1041-7. DOI: 10.1007/s11695-015-1825-1. View

13.

Hotamisligil G . Inflammation and metabolic disorders. Nature. 2006; 444(7121):860-7. DOI: 10.1038/nature05485. View

14.

Pelascini E, Disse E, Pasquer A, Poncet G, Gouillat C, Robert M . Should we wait for metabolic complications before operating on obese patients? Gastric bypass outcomes in metabolically healthy obese individuals. Surg Obes Relat Dis. 2015; 12(1):49-56. DOI: 10.1016/j.soard.2015.04.024. View

15.

Tang Y, Zhang M, Hellmann J, Kosuri M, Bhatnagar A, Spite M . Proresolution therapy for the treatment of delayed healing of diabetic wounds. Diabetes. 2012; 62(2):618-27. PMC: 3554373. DOI: 10.2337/db12-0684. View

16.

Bays H . Current and investigational antiobesity agents and obesity therapeutic treatment targets. Obes Res. 2004; 12(8):1197-211. DOI: 10.1038/oby.2004.151. View

17.

Kalinowski P, Paluszkiewicz R, Wroblewski T, Remiszewski P, Grodzicki M, Bartoszewicz Z . Ghrelin, leptin, and glycemic control after sleeve gastrectomy versus Roux-en-Y gastric bypass-results of a randomized clinical trial. Surg Obes Relat Dis. 2016; 13(2):181-188. DOI: 10.1016/j.soard.2016.08.025. View

18.

Tonjes A, Bluher M, Stumvoll M . Retinol-binding protein 4 and new adipocytokines in nonalcoholic fatty liver disease. Curr Pharm Des. 2010; 16(17):1921-8. DOI: 10.2174/138161210791208938. View

19.

Tauman R, Shalitin S, Lavie L . Oxidative stress in obese children and adolescents with and without type 2 diabetes mellitus is not associated with obstructive sleep apnea. Sleep Breath. 2018; 23(1):117-123. DOI: 10.1007/s11325-018-1670-2. View

20.

Balejko E, Balejko J, Plust D . Assessment of the Effect of Dietary Modifications and Bioenteric Intragastric Balloon Treatment on the Changes of Some Morphological and Biochemical Parameters in Obese Patients. Ann Nutr Metab. 2018; 73(4):290-301. DOI: 10.1159/000493274. View